PPARα (also known as NR1C1), a ligand-activated nuclear receptor, has been associated with cell survival in cancer because of its effects on glycolytic metabolic pathways and lipid metabolism in cancer cells 39, 40. This evidence concerns the gene PPARA and cancer.